Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Literature DB >> 1107513

Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

L A Pagliaro, L Z Benet.

Abstract

Entities: Disease Species

Mesh：

Year: 1975 PMID： 1107513 DOI： 10.1007/bf01082306

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

310 in total

1. CEPHALOTHIN SERUM LEVELS IN THE AZOTEMIC PATIENT.

Authors: S A KABINS; S COHEN
Journal: Antimicrob Agents Chemother (Bethesda) Date: 1964

2. Control of urine pH and its effect on sulfaethidole excretion in humans.

Authors: H B KOSTENBAUDER; J B PORTNOFF; J V SWINTOSKY
Journal: J Pharm Sci Date: 1962-11 Impact factor: 3.534

3. Streptomycin in the blood; chemical determinations after single and repeated intramuscular injections.

Authors: G E BOXER; V C JELINEK
Journal: J Pharmacol Exp Ther Date: 1948-03 Impact factor: 4.030

4. [Amoxycillin: pharmacokinetics and experience in the treatment of urinary tract infections].

Authors: P Fiegel; D Höffler; H Köhler; H J Werner
Journal: Chemotherapy Date: 1973 Impact factor: 2.544

5. Bioavailability studies of acetaminophen and nitrofurantoin.

Authors: K S Albert; A J Sedman; P Wilkinson; R G Stoll; W J Murray; J G Wagner
Journal: J Clin Pharmacol Date: 1974 May-Jun Impact factor: 3.126

6. Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

Authors: M Rowland; S Riegelman; P A Harris; S D Sholkoff
Journal: J Pharm Sci Date: 1972-03 Impact factor: 3.534

7. [Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].

Authors: H Held; B Kaminski; H F von Oldershausen
Journal: Diabetologia Date: 1970-08 Impact factor: 10.122

8. Pharmacokinetic study of doxycycline in children.

Authors: G Ceccarelli; R Rossoni; F Romita; A Naddeo
Journal: Chemotherapy Date: 1971 Impact factor: 2.544

9. Pharmacokinetics of salicylate elimination in man.

Authors: G Levy
Journal: J Pharm Sci Date: 1965-07 Impact factor: 3.534

10. The metabolism of diphenylhydantoin (Dilantin) following once-daily administration.

Authors: R A Buchanan; A W Kinkel; J R Goulet; T C Smith
Journal: Neurology Date: 1972-02 Impact factor: 9.910

9 in total

1. Alcohol metabolism.

Authors: L Pagliaro; A M Pagliaro
Journal: CMAJ Date: 1992-06-15 Impact factor: 8.262

2. Effect of vitamin C supplement on antipyrine disposition in man.

Authors: J B Houston
Journal: Br J Clin Pharmacol Date: 1977-04 Impact factor: 4.335

Review 3. Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors: U Klotz
Journal: Clin Pharmacokinet Date: 2000-03 Impact factor: 6.447

Review 4. Pharmacokinetics of the penicillins in man.

Authors: M Barza; L Weinstein
Journal: Clin Pharmacokinet Date: 1976 Impact factor: 6.447

Review 5. The pharmacological role of the kidney.

Authors: D C Brater
Journal: Drugs Date: 1980-01 Impact factor: 9.546

Review 6. Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors: D E Drayer
Journal: Clin Pharmacokinet Date: 1976 Nov-Dec Impact factor: 6.447